Saturday, November 21, 2009

Cholesterol Home>
News>
FDA rejects Lipitor/Zetia combo drug application

Font size
- A
- A
- A
Email This

Bookmark

Save

FDA rejects Lipitor/Zetia combo drug application

(Covenant Health System) UPDATED 2009-11-03

The U.S. Food and Drug Administration (FDA) has rejected an application for a new cholesterol pill that combines Lipitor and Zetia, saying the agency needs more information about the stability and manufacturing of the drug. Drugmaker Merck plans to address the FDA's concerns and resubmit the application. Read full story >

See all Cholesterol News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Non-Profit Affiliates:

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on CholesterolNetwork.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.